India's drug controller clears Bharat Biotech's nasal vaccine against COVID-19 for emergency use

STORY: India's drug controller clears Bharat Biotech's nasal vaccine against COVID-19 for emergency use DATELINE: Sept. 7, 2022 LENGTH: 00:01:31 LOCATION: New Delhi CATEGORY: HEALTH SHOTLIST: 1. various of of India gate 2. various of hospital area 3. various of vaccination centre 4. various of traffic STORYLINE: India's federal health minister Mansukh Mandaviya said on Tuesday the Central Drugs Standard Control Organisation (CDSCO) has cleared vaccine maker Bharat Biotech's nasal vaccine against COVID-19 for emergency use. Mandaviya has described the development as a big boost to the ongoing fight against COVID-19. "Big Boost to India's Fight Against COVID-19! Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by CDSCO for primary immunization against COVID-19 in 18 plus age group for restricted use in emergency situation," Mandaviya said in a brief statement posted on social media. The health minister said the step would further stre